Display options
Cite
Anders B, Shillingburg A, Newton M. Oral Antineoplastic Agents: Assessing the Delay in Care. Chemother Res Pract. 2015;2015:512016doi: 10.1155/2015/512016.
Anders, B., Shillingburg, A., & Newton, M. (2015). Oral Antineoplastic Agents: Assessing the Delay in Care. Chemotherapy research and practice, 2015512016. https://doi.org/10.1155/2015/512016
Anders, Brandi, et al. "Oral Antineoplastic Agents: Assessing the Delay in Care." Chemotherapy research and practice vol. 2015 (2015): 512016. doi: https://doi.org/10.1155/2015/512016
Anders B, Shillingburg A, Newton M. Oral Antineoplastic Agents: Assessing the Delay in Care. Chemother Res Pract. 2015;2015:512016. doi: 10.1155/2015/512016. Epub 2015 Oct 28. PMID: 26605087; PMCID: PMC4641173.
Copy Download .nbib Format: NLM
Share it on

Chemother Res Pract. 2015;2015:512016. doi: 10.1155/2015/512016. Epub 2015 Oct 28.

Oral Antineoplastic Agents: Assessing the Delay in Care.

Chemotherapy research and practice

Brandi Anders, Alexandra Shillingburg, Michael Newton

Affiliations

  1. Wake Forest Baptist Health, Medical Center Boulevard, Winston-Salem, NC 27157, USA.
  2. West Virginia University Healthcare, 1 Medical Center Drive, Morgantown, WV 26506, USA.
  3. West Virginia University Healthcare, 1 Medical Center Drive, Morgantown, WV 26506, USA ; Clinical Department, West Virginia University School of Pharmacy, Morgantown, WV 26506, USA.

PMID: 26605087 PMCID: PMC4641173 DOI: 10.1155/2015/512016

Abstract

The study was undertaken to determine the length of time between when a prescription for an oral antineoplastic agent is written by the provider and when the medication is received by the patient and to identify risk factors that significantly increase time to medication receipt. First-time fill prescriptions for oral antineoplastic agents were identified. The date the prescription was written and received by the patient was determined. A retrospective review was completed to gather additional information, including prescribed medication, indication, insurance coverage, patient assistance program use, dispensing pharmacy, and prior authorization requirements. The data was analyzed through multivariate statistical analysis and used to identify risk factors that may significantly increase the time to medication receipt. A total of 58 patients were included in the study. A median of 8 days elapsed between when the medication was prescribed and when it was received by the patient. Medication prescribed, absence of a Risk Evaluation Mitigation Strategies (REMS) program, and insurance type are factors that increased time to medication receipt. An understanding of the median time involved, as well as factors affecting the time to delivery of prescriptions, will help healthcare providers better plan and prepare for the use of oral antineoplastic agents.

References

  1. Pharmacotherapy. 2014 May;34(5):481-94 - PubMed
  2. Anticancer Res. 2014 Apr;34(4):1573-8 - PubMed
  3. Health Aff (Millwood). 2006 Sep-Oct;25(5):1240-8 - PubMed
  4. Cancer Treat Rev. 2010 Dec;36(8):595-605 - PubMed
  5. J Natl Compr Canc Netw. 2008 Mar;6 Suppl 3:S1-14 - PubMed
  6. J Oncol Pract. 2011 May;7(3 Suppl):46s-51s - PubMed

Publication Types